8-K
filed May 17, 2024, 7:59 PM ET
CIK 0001773427
other
confidence high
sentiment neutral
materiality 0.10
SpringWorks stockholders re-elect Freda Lewis-Hall as director, ratify EY, approve say-on-pay
SpringWorks Therapeutics, Inc.
- Freda Lewis-Hall elected Class II director: 50.3M for, 15.8M withheld, 3.4M abstentions.
- Ratification of Ernst & Young as FY2024 auditor: 69.5M for, 5,709 against, 10,294 abstentions.
- Non-binding advisory vote on executive compensation approved: 38.3M for, 27.8M against, 3.4M abstentions.
- All three proposals passed at May 16, 2024 annual meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
SpringWorks Therapeutics, Inc. shareholders approved Non-Binding Advisory Vote on Executive Compensation at the 2024-05-16 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 3 - Non-Binding Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement for the annual meeting of stockholders. The results of such vote were as follows: Votes For Votes Against Abstentions/ Non-Votes 38,332,463 27,761,536 3,407,326
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
SpringWorks Therapeutics, Inc. shareholders approved Election of Freda Lewis-Hall as Class II Director at the 2024-05-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 1 - Election of Directors The stockholders elected the person named below to serve as a Class II director of the Company for a three-year term that expires at the Company’s annual meeting of stockholders in 2027 and until her successor has been duly elected and qualified, subject to her earlier death, resignation or removal. The results of such vote were as follows: Director Name Votes For Withheld Abstentions/ Non-Votes Freda Lewis-Hall 50,328,375 15,800,834 3,372,116
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
SpringWorks Therapeutics, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm at the 2024-05-16 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The results of such vote were as follows: Votes For Votes Against Abstentions 69,485,322 5,709 10,294
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.